/Companies

ReEngage Therapeutics

Houston, US · Founded 2024 · Delaware corporation

Find your way into ReEngage Therapeutics

Sign up to see every warm intro you have to ReEngage Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ReEngage Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

TKThomas Kim
Thomas KimPresident and CEOExecutive Officer, Director at EpiVario

Reported raises · per SEC filings

Form D private placements

$430K disclosed across 2 rounds · 2024–2025

▶$365KraisedJul 2025 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas KimExecutive Officer, Director
Offering amount
$8M
Amount sold
$365K
Proceeds to insiders
$25K
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$65KraisedDec 2024 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas KimExecutive Officer, Director
Offering amount
$3M
Amount sold
$65K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has ReEngage Therapeutics raised?
ReEngage Therapeutics has disclosed $430K raised across 2 rounds.
Where is ReEngage Therapeutics headquartered?
ReEngage Therapeutics is headquartered in Houston, US.